These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17397570)

  • 61. Clostridium difficile colitis: a review.
    Moudgal V; Sobel JD
    Hosp Pract (1995); 2012 Feb; 40(1):139-48. PubMed ID: 22406889
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibiotic-induced diarrhea and pseudomembranous colitis.
    Jacobs NF
    Postgrad Med; 1994 Jun; 95(8):111-4, 117-20. PubMed ID: 8202415
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clostridium difficile infection in the intensive care unit.
    Leclair MA; Allard C; Lesur O; Pépin J
    J Intensive Care Med; 2010; 25(1):23-30. PubMed ID: 20034951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis and treatment of Clostridium difficile colitis.
    Fekety R; Shah AB
    JAMA; 1993 Jan; 269(1):71-5. PubMed ID: 8416409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clostridium difficile--Associated diarrhea: A review.
    Mylonakis E; Ryan ET; Calderwood SB
    Arch Intern Med; 2001 Feb; 161(4):525-33. PubMed ID: 11252111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repeat Clostridium difficile Testing.
    Gupta A; Khanna S
    JAMA; 2016 Dec; 316(22):2422-2423. PubMed ID: 27959982
    [No Abstract]   [Full Text] [Related]  

  • 69. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clostridium difficile infections in geriatric patients].
    Simmerlein R; Basta A; Gosch M
    Z Gerontol Geriatr; 2016 Dec; 49(8):743-761. PubMed ID: 27785569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Meeting the challenge of recurrent Clostridium difficile infection.
    Johnson S
    J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital.
    Cappell MS; Philogene C
    Am J Gastroenterol; 1993 Jun; 88(6):891-7. PubMed ID: 8503386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clostridium difficile infection in children--experience of clinical centre in Bydgoszcz].
    Duleba K; Smukalska E; Pawłowska M
    Przegl Epidemiol; 2012; 66(1):67-71. PubMed ID: 22708301
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clostridium difficile infection: responses, relapses and re-infections.
    Wilcox MH; Spencer RC
    J Hosp Infect; 1992 Oct; 22(2):85-92. PubMed ID: 1358964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.
    Pant C; Sferra TJ; Deshpande A; Minocha A
    Eur J Intern Med; 2011 Dec; 22(6):561-8. PubMed ID: 22075280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
    Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of Benefit With Combination Therapy for Clostridium difficile Infection.
    Njoku JC; Van Schooneveld TC; Rupp ME; Olsen KM; Qiu F; Meza JL; Hermsen ED
    Infect Control Hosp Epidemiol; 2017 May; 38(5):602-605. PubMed ID: 28162100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibiotic-associated diarrhea and Clostridium difficile colitis: an update.
    Giannella RA
    Rev Esp Enferm Dig; 2001 Aug; 93(8):535-43. PubMed ID: 11692783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.